Reuters logo
BRIEF-Eagle Pharmaceuticals says in connection with appointment as president of co, David Pernock resigned from board - SEC filing
January 6, 2017 / 9:55 PM / 9 months ago

BRIEF-Eagle Pharmaceuticals says in connection with appointment as president of co, David Pernock resigned from board - SEC filing

Jan 6 (Reuters) - Eagle Pharmaceuticals Inc

* Eagle Pharmaceuticals - on January 2, 2017, in connection with appointment as president of co, David Pernock resigned from board of co - SEC filing

* Eagle Pharmaceuticals - in addition, in connection with Pernock’s appointment, Scott Tarriff resigned as president of co, effective January 2, 2017

* Eagle Pharmaceuticals - Tarriff will continue to serve as the company's chief executive officer and as a member of the board Source text: (bit.ly/2iZLYwZ) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below